Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18244
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAndonopoulos, A. P.en
dc.contributor.authorDrosos, A. A.en
dc.contributor.authorSkopouli, F. N.en
dc.contributor.authorMoutsopoulos, H. M.en
dc.date.accessioned2015-11-24T18:51:20Z-
dc.date.available2015-11-24T18:51:20Z-
dc.identifier.issn0392-856X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18244-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectArthritis, Rheumatoid/*complications/diagnosisen
dc.subjectAutoantibodies/analysisen
dc.subjectAutoantigens/immunologyen
dc.subjectDiagnosis, Differentialen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHyperplasiaen
dc.subjectKeratoconjunctivitis Sicca/complications/diagnosisen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectParotid Gland/pathologyen
dc.subjectProspective Studiesen
dc.subject*RNA, Small Cytoplasmicen
dc.subject*Ribonucleoproteinsen
dc.subjectScleroderma, Systemic/*complications/diagnosisen
dc.subjectSjogren's Syndrome/*complications/diagnosisen
dc.titleSjogren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative studyen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2736835-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1989-
heal.abstractOne hundred and eleven patients with rheumatoid arthritis (RA) and 44 with progressive systemic sclerosis (PSS) were prospectively evaluated for evidence of Sjogren's syndrome (Ss). The diagnosis was established when a patient with a lip biopsy focal lymphocytic infiltration score of greater than or equal to 2+ in Tarpley's scale had keratoconjunctivitis sicca (KCS) and/or xerostomia. Out of 44 RA and 10 PSS patients with positive lip biopsy, 34 and 9 had criteria for Ss respectively, suggesting a 31% prevalence of Ss in RA and a 20.5% in PSS. Six per cent of the RA patients spontaneously offered complaints of subjective xerophthalmia whereas 11.1% and 22.2% of those with PSS did so for subjective xerophthalmia and xerostomia respectively. However, specific questionnaire elicited subjective xerophthalmia in 38.2% and subjective xerostomia in 5.9% of the RA patients, whereas in 55.5% and 66.7% of the PSS ones respectively. Parotid gland enlargement was detected in 20.6% of the RA and in 44.4% of the PSS patients with Ss. Anti-Ro (SSA) antibodies were present in the sera of 23.5% and 33.3% of them respectively. Severe extraglandular manifestations were unusual in both groups. Our results suggest that, although both Ss in RA and that in PSS lack prominent exocrine gland symptomatology, certain differences between the two and similarities of the latter to primary Ss, would not justify the term 'secondary Ss' for the syndrome accompanying scleroderma, as it has been applied to that accompanying RA.en
heal.journalNameClin Exp Rheumatolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons